UNIGE document Scientific Article
previous document  unige:43569  next document
add to browser collection

Complete remission with tyrosine kinase inhibitors in renal cell carcinoma

Albiges, Laurence
Oudard, Stéphane
Negrier, Sylvie
Caty, Armelle
Gravis, Gwenaëlle
Joly, Florence
Duclos, Brigitte
Geoffrois, Lionel
show hidden authors show all authors [1 - 16]
Published in Journal of Clinical Oncology. 2012, vol. 30, no. 5, p. 482-7
Abstract Complete remission (CR) is uncommon during treatment for metastatic renal cell carcinoma (mRCC) with tyrosine kinase inhibitors (TKIs), but it may occur in some patients. It remains a matter of debate whether therapy should be continued after CR.
Keywords AdultAgedAntineoplastic Agents/therapeutic useBenzenesulfonates/therapeutic useCarcinoma, Renal Cell/drug therapy/secondary/surgeryFeasibility StudiesFemaleHumansIndoles/therapeutic useKidney Neoplasms/drug therapy/pathology/surgeryMaleMedical RecordsMiddle AgedMolecular Targeted TherapyNephrectomyNiacinamide/analogs & derivativesPhenylurea CompoundsProtein Kinase Inhibitors/therapeutic useProtein-Tyrosine Kinases/antagonists & inhibitorsPyridines/therapeutic usePyrroles/therapeutic useQuestionnairesRemission InductionRetrospective StudiesTreatment Outcome
PMID: 22231040
Full text
Article (Published version) (128 Kb) - public document Free access
Research group Immunothérapie des cancers (42)
(ISO format)
ALBIGES, Laurence et al. Complete remission with tyrosine kinase inhibitors in renal cell carcinoma. In: Journal of Clinical Oncology, 2012, vol. 30, n° 5, p. 482-7. doi: 10.1200/JCO.2011.37.2516 https://archive-ouverte.unige.ch/unige:43569

501 hits



Deposited on : 2014-12-16

Export document
Format :
Citation style :